why choose us

First received: June 19, 2023

Clinical Trial: Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Mastocytosis, Indolent Systemic

Study Type: OBSERVATIONAL


Official Title: Evaluation of the Disability-Adjusted Life Year (DALY) on a Cohort of Patients With Indolent Systemic Mastocytosis (ISM)

Brief Summary: Mastocytosis is a group of pathologies characterized by the accumulation and/or clonal proliferation of abnormal mast cells in various organs.The impact of mastocytosis on health, quality of life, the psychoaffective sphere and on professional life constitutes the burden of this disease.The DALY is the disability-adjusted life expectancy, which takes into account the life expectancy and the number of years "lost" due to illness, disability or early death.Due to the major impact of the disease this…

Read more